Efficacy of Oral Nicorandil to Prevent Contrast-Induced Nephropathy in Patients with Chronic Renal Dysfunction Undergoing an Elective Coronary Procedure
Objectives: This prospective, randomized study was to investigate the role of nicorandil in the prevention of contrast-induced nephropathy (CIN) in patients with chronic renal dysfunction undergoing an elective coronary procedure. Methods: A total of 252 eligible patients were enrolled in this study...
Main Authors: | Zeyuan Fan, Yang Li, Hanhua Ji, Xinwen Jian |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2019-10-01
|
Series: | Kidney & Blood Pressure Research |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/503160 |
Similar Items
-
Preventive Effect of Pretreatment with Pitavastatin on Contrast-Induced Nephropathy in Patients with Renal Dysfunction Undergoing Coronary Procedure: PRINCIPLE-II Randomized Clinical Trial
by: Woong Chol Kang, et al.
Published: (2020-11-01) -
Prevention of contrast induced nephropathy; a cardiology point of view
by: Hashemi Mohammad, et al.
Published: (2015-01-01) -
Risk of Contrast-Induced Nephropathy after Repeated Contrast Medium Administration
by: Dinesch Violeta, et al.
Published: (2018-09-01) -
Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention
by: Jun-yi Zhang, et al.
Published: (2019-07-01) -
Contrast-induced nephropathy
by: O Iu Mironova
Published: (2013-06-01)